Histopathological lesions following intramuscular administration of saline in laboratory rodents and rabbits
Introduction
The intramuscular route is a common route of administration for many pharmaceutical products, in particular, vaccines and veterinary medicines. This route of exposure is, therefore, also employed in toxicology studies on these products. During the course of a toxicology study, control animals receive the same injected volume as treated animals, but they receive either saline or vehicle. Histopathological changes at injection sites are often noted in controls secondarily to the administration procedure of saline (damage by the needle and effects of the volume of saline). Though their severity is usually minimal, the interpretation of histological changes seen in such studies relies heavily on the ability to distinguish between the changes induced by the administration procedures and a response to the test article.
The histopathological changes seen following the intramuscular administration of saline have not previously been well-documented. Most of the published studies report lesions following intramuscular injections of specific compounds like antibiotics or local anaesthetics or of vehicle or adjuvant (such as aluminium hydroxide) (Steiness et al., 1978; Svendsen and Blom, 1984; Diness, 1985; Manor and Sadeh, 1989; Svendsen et al., 1998). Several publications discuss the effects of volume, concentration, vehicle, pH, temperature and injection speed on muscular lesions in different species such as rabbits, pigs or mice (Svendsen and Blom, 1984; Svendsen et al., 1998). The aim of this study was to evaluate the histological changes recorded following intramuscular injections of saline, either after single or repeated administration in rats, rabbits and mice, using data collected from 7 toxicology studies. As the data were derived from previously conducted studies, it was essential to ensure that the terminology was standardized, particularly as the evaluation was across species.
Section snippets
Animals
Seven studies testing vaccine, adjuvanted vaccine or adjuvant alone were considered with mice, rats and rabbits obtained from Charles River Laboratory. Mice were Swiss OF1 strain of 8 weeks of age and 24–31 g body weight at initiation of treatment. Rats were Ico or Wistar strains of six weeks of age and 140–220 g body weight at initiation of treatment. Rabbits were New Zealand white KBL strain of 12–14 weeks of age and 2 and 3 kg body weight at initiation of treatment.
Mice were housed singly,
Terminology
The data from both control and treated animals was used to generate standardized terminology suitable for injection sites (Table 1). Details about this terminology regarding aspects of inflammation, degeneration and repair are described below. Lesions and their incidence for animals given saline are presented in Table 2.
Discussion
The intramuscular route is frequently used in toxicology studies, particularly on vaccines, and there is little published data reporting background lesions in intramuscular studies. The pathologist must have a good knowledge of the type and incidence of procedure-related lesions and should use consistent terminology across studies.
The data presented here represent a firm basis for a better interpretation of treatment-related changes in this test system. Influence of time between last injection
Acknowledgments
The authors wish to thank all of their colleagues who helped in the compilation of these data, particularly the archivists, Agnès Tortochaut and Annie Roche.
References (11)
- et al.
European federation of pharmaceutical industries association and European centre for the validation of alternative methods, EFPIA/ECVAM. A good practice guide to the administration of substances and removal of blood, including routes and volumes
J Appl Toxicol
(2001) Local tissue damage after intramuscular injections in rabbits and pigs: quantitation by determination of creatine kinase activity at injection sites
Acta Pharmacol Toxicol (Copenh)
(1985)- et al.
Muscle fibre necrosis induced by intramuscular injection of drugs
Br J Exp Pathol
(1989) - et al.
Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
Gene Ther
(1998) Guide for the care and use of laboratory animals
(1996)
Cited by (36)
The value of MRI STIR signal intensity on return to play prognosis and reinjury risk estimation in athletes with acute hamstring injuries
2021, Journal of Science and Medicine in SportDevelopment and characterization of a plant-derived rotavirus-like particle vaccine
2021, VaccineCitation Excerpt :G1 Ro-VLP was well tolerated in this study with no systemic sign of toxicity in rabbits. Histological changes at injection sites were attributed to the administration procedures [50] and to the adjuvant component used in the G1 Ro-VLP groups [51]. Four weeks after the final administration, partial resolution of findings previously seen at the injection sites was noted, and no delayed systemic toxic or local effects were seen.
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
2021, Advanced Drug Delivery ReviewsCitation Excerpt :It is possible that some promising candidates may present life-threatening toxicity and could not be picked up during in vitro or in vivo studies. More severe adverse events including trauma, macrophagic mypfasitis (MMF), enhanced diseases, and autoimmune diseases have been reported previously in toxicology studies of other vaccines [195–198]. These studies demonstrate the double-edged potential of vaccine-mediated immune-stimulation.
Sedative effects of intramuscular alfaxalone in pet guinea pigs (Cavia porcellus)
2018, Veterinary Anaesthesia and AnalgesiaCitation Excerpt :Moreover, because alfaxalone is only available in Europe at a concentration of 10 mg mL–1 doses, doses higher than 5 mg kg−1 would result in unacceptably high IM injection volumes for small rodents. It has been demonstrated that histopathological lesions of the skeletal muscles may result not only from the drug's chemical characteristics but also from mechanical compression when large volumes are injected (Evans 2005; Thuilliez et al. 2009). This represents a major limitation when dealing with smaller mammals and, as previously advocated by other investigators, the commercialization of more concentrated solutions might partially overcome this issue (Tamura et al. 2015b).
Skeletal Muscle
2017, Boorman's Pathology of the Rat: Reference and Atlas